EINPresswire-599094831-women-s-health-diagnostics-market-genome-editing-breakthroughs-to-drive-the-industry (1)
                     Women’s Health Diagnostics Market: Genome
editing breakthroughs to drive the industry
North America dominated the Women’s
Health Diagnostics market in 2021,
accounting for more than 42% of global
revenue.
PUNE, MAHARASHTRA, INDIA,
November 2, 2022 /EINPresswire.com/
-- Maximize Market Research has
published a report on the Women’s
Health Diagnostics Market that
provides a detailed analysis for the
forecast period of 2022 to 2029.
According to the report, the Women’s
Health Diagnostics Market was valued
at USD 27.1 Billion in 2021 and is
Womens Health Diagnostics Market
expected to reach USD 52.1 Billion by
2029, at a CAGR of 8.5% during the
forecast period.
https://www.maximizemarketresearch.com/market-report/womens-health-diagnostics-
market/161131/
To Get a Sample Copy of the Women’s Health Diagnostics
Market, Click Here:
https://www.maximizemarketresearch.com/request-
Based on the End Use, In
sample/161131
2021, hospitals and
diagnostics centers held the
Women’s Health Diagnostics Market Report Scope &
highest share in women's
Research Methodology:
health diagnostics market”
MMR
The research includes complete market insights for
industry stakeholders, including an explanation of complex market statistics in clear terms, the
history and current state of the industry, as well as estimated market size and trends. The study
looks at all industry segments (Application, End-Use, and Region), with a focus on major firms
such as market leaders, followers, and new entrants. The report is an investor's guide since it
provides a comprehensive picture of the competitive landscape of leading players in the
Women’s Health Diagnostics market by goods and services, revenue, financial status, portfolio,
growth strategies, and geographical presence.
Secondary research is used to identify key companies in the Women’s Health Diagnostics market,
while primary and secondary research is used to determine their market revenues. Interviews
with key opinion leaders and industry specialists such as competent front-line staff,
entrepreneurs, and marketing professionals were conducted as part of primary research, while a
review of annual and financial reports of prominent manufacturers was conducted as part of
secondary research. Quest Diagnostics Incorporated, Hologic, Inc., Siemens AG, and PerkinElmer,
Inc. are some of the major players in the global Women’s Health Diagnostics market, and the
report not only represents global companies but also includes the market holdings of local
players in each country. The market structure illustrated in each country, with market holdings
by market leaders, followers, and local companies, provides a full insight into the research. The
report covers the market's mergers and acquisitions, strategic alliances, joint ventures, and
partnerships by region, investment, and strategic intent.
Women’s Health Diagnostics Market Overview:
Women's Health Diagnostics refers to the branch of medicine that focuses on the treatment and
diagnosis of diseases and conditions that affect a woman’s physical and emotional well-being.
Several companies offer women’s health diagnostics including gynecologic /cytology/tissue and
breast tissue assessments. As women have unique health issues due to unprecedented social,
biological, and behavioral conditions, several companies are focusing voluntarily on Women's
Health Diagnostics, providing several healthcare packages, and consultation services. Over the
last decade, there has been a significant increase in global demand for various health diagnostic
tests. The market is currently being driven primarily by increased awareness of various health-
related issues, the rising incidences of chronic and lifestyle disorders, and the high prevalence of
infectious diseases such as HIV and hepatitis in women on a global scale. During the forecast
period, the market is expected to grow due to the increased use of point-of-care diagnostic
testing and an increase in the number of diagnostic and imaging facilities. 
Women’s Health Diagnostics Market Dynamics:
The rising prevalence of infectious diseases among women, such as hepatitis and urinary tract
infections, is expected to drive Women’s Health Diagnostics market growth during the forecast
period. Early detection of any health issue is critical using digital and mobile mammography, as
well as breast MRI, ultrasound, and bone density testing. Medical science advancements provide
lucrative opportunities to control women-centric conditions such as infectious diseases,
osteoporosis, and breast cancer. According to data published by the National Centre for
Biotechnology Information (NCBI), women are 30.0% more likely than men to be infected with
HIV which is further creating a growth opportunity for the Women's Health Diagnostic Market.
With increasing women's health awareness and illness load, there is a global demand for
imaging and diagnostics facilities. Because the majority of diagnostic and imaging tests are
performed in centers, the market is expected to grow rapidly. According to a United Nations,
Food and Drug Administration (USFDA) page titled "Mammography Quality Standards Act and
Program (MQSA) National Statistics" updated in November 2021, as of November 1st, 2021,
there are 23,590 certified mammography units in the United States. Out of the total of 13,125
authorized Full Field Digital Mammography and Computed Radiography Units, there are 10,458
Digital Breast Tomosynthesis Units. It also stated that as of October 2020, there were 8,718
approved facilities, but the number rose to 8,733 by November 2021.
Women’s Health Diagnostics Market Regional Insights:
North America dominated the overall Women’s Health Diagnostics market in 2021, accounting
for more than 42% of global revenue. Over the forecast period, the regional market is expected
to grow at a steady CAGR while maintaining its market position. The growth is attributed to early
product approval and commercialization, favorable reimbursement policies, supportive
government regulations, and widespread awareness of the importance of maintaining good
health.
Regional growth is expected to be driven by a strong market presence by leading market players
delivering technologically sophisticated products for women's health diagnostics. For example, In
March 2021, Lia introduced the world's first flushable and biodegradable pregnancy test. Lia's
pregnancy tests are made from plant fibers and contain no plastic, so they biodegrade in just ten
weeks. Better healthcare infrastructure increased awareness of women's health issues, and
increased female labor-force participation are all expected to drive regional market growth.
Women’s Health Diagnostics Market Segmentation:
By Application:  
• Cancer
Breast Cancer Testing
Cervical Cancer Testing
Ovarian Cancer Testing
• Infectious Disease Testing
• Osteoporosis Testing
• Pregnancy and Fertility Testing
• Prenatal Testing
By End Use:  
• Hospital and Diagnostics Centers
• Diagnostic and Imaging Centers
• Home Care Settings
Women’s Health Diagnostics Market Key Competitors:
• Quest Diagnostics Incorporated
• Hologic, Inc.
• Siemens AG
• PerkinElmer, Inc.
• F. Hoffmann-La Roche Ltd.
• Cardinal Health, Inc.
• General Electric Company
• Becton
• Dickinson and Company
• Abbott Laboratories
• bioMérieux SA
• Koninklijke Philips N.V.
• Guided Therapeutics, Inc.
• SuperSonic Imagine
• FUJIFILM Holdings Corporation
• DIALAB GmbH
• Carestream Health, Inc.
• MedGyn Products, Inc.
• Cook Medical, Inc.
• Osteometer MediTech, Inc
• NeuroLogica Corporation
Key Questions answered in the Women’s Health Diagnostics Market Report are: 
What is the competitive scenario of the Women’s Health Diagnostics Market?
Which are the key factors aiding the Women’s Health Diagnostics Market growth?
Which region is expected to hold the largest share of the Women’s Health Diagnostics Market by
2029?
What will be the CAGR of the Women’s Health Diagnostics Market during the forecast period?
Which are the prominent players in the Women’s Health Diagnostics Market?
What key trends are likely to emerge in the Women’s Health Diagnostics Market the during the
forecast period?
What is the expected Women’s Health Diagnostics Market size by 2029?
Which company held the largest share of the Women’s Health Diagnostics Market in 2021?
Which application segment is expected to emerge as the leading segment in the Women’s Health
Diagnostics Market?
Which product segment held the largest share of the Women’s Health Diagnostics Market in
2021?
Key Offerings:
Market Share, Size & Forecast by Revenue | 2022−2029
Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
Market Segmentation – A detailed analysis by Application, End-Use, and Region
Competitive Landscape – Key Vendors and Other Prominent Vendors
Directly Purchase a copy of the Women’s Health Diagnostics Market report:  
Maximize Market Research a leading healthcare research firm has also published the following
reports:
In Vitro Diagnostics Quality Control Market - In Vitro Diagnostics Quality Control Market size is
expected to reach USD 2.58 Billion by 2029, at a CAGR of 5.5% during the forecast period. In Vitro
Diagnostics (IVD) is a critical and rapidly growing part of the global healthcare system that
benefits patients, medical professionals, and the industry while also enhancing population well-
being.
Liver Cancer Diagnostics Market – Liver Cancer Diagnostics Market size is expected to reach USD
2.81 Billion by 2029, at a CAGR of 8.42% during the forecast period. The global liver cancer
diagnostics market is expected to grow as the prevalence of alcohol addiction grows.
Cancer Diagnostics Market – Cancer Diagnostics Market size is expected to reach USD 46.45
Billion by 2029, at a CAGR of 11.6% during the forecast period. The global cancer diagnostics
market is growing rapidly as the incidence and prevalence of various cancer kinds grow, as do
government initiatives and other organizations aimed at raising cancer awareness.
Lung Cancer Diagnostics Market – Lung Cancer Diagnostics Market size is expected to reach USD
3.88 Billion by 2029, at a CAGR of 7.31% during the forecast period. Asia Pacific dominated the
lung cancer diagnostics market in 2021 and is expected to grow at a CAGR of 5.7% during the
forecast period.
https://www.maximizemarketresearch.com/market-report/global-lung-cancer-diagnostics-
market/113284/ 
Diabetes Diagnostics Market – Diabetes Diagnostics Market size is expected to reach USD 48.69
Billion by 2029, at a CAGR of 7.8% during the forecast period. Increased knowledge of
preventative measures and new variables is beneficial to the diabetes diagnostics industry's
growth.
Respiratory Diagnostics Market – Respiratory Diagnostics Market size is expected to reach USD
13.91 Billion by 2029, at a CAGR of 7.3% during the forecast period. In the forecast period, the
installation of diagnostic instruments in multispecialty hospitals and private hospitals, healthcare
centers, and government efforts such as healthcare programs are expected to drive market
growth.
About Maximize Market Research:
Maximize Market Research provides syndicate as well as custom-made business and market B2B
and B2C research on 6,500 high-growth emerging technologies and opportunities as well as
threats to the companies across the  Chemical, Healthcare, Pharmaceuticals, Electronics and
Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other
manufacturing sectors. Maximize Market Research is positioned to estimate and forecast the
market size with the competitive landscape of the industries. Additional information is available
at https://www.maximizemarketresearch.com/.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
[email protected]
+91 96071 95908, +91 9607365656
Geeta Yevale
Maximize Market research
+91 72638 03166
email us here
Visit us on social media:
LinkedIn
This press release can be viewed online at: https://www.einpresswire.com/article/599094831
EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors
try to be careful about weeding out false and misleading content. As a user, if you see something
we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire,
Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable
in today's world. Please see our Editorial Guidelines for more information.
© 1995-2022 Newsmatics Inc. All Right Reserved.